CRH Medical Corp (CRMMF) 3.7300 $CRMMF OTC Mark
Post# of 273322
Posted On: 06/09/2016 5:00:56 AM
CRH Medical Corp (CRMMF) 3.7300 $CRMMF
OTC Markets Group Congratulates CRH Medical on NYSE MKT Listing
PR Newswire - Thu Sep 03, 12:54PM CDT
OTC Markets Group Inc. (OTCQX: OTCM) is pleased to congratulate CRH Medical Corp., a provider of innovative products and services for the treatment of gastrointestinal diseases, on its NYSE MKT listing. CRH Medical previously traded on the OTCQX® Best Market operated by OTC Markets Group.
CRH Medical Corporation To Commence Trading on the NYSE MKT Under the Symbol "CRHM"
Marketwired - Tue Sep 01, 7:31AM CDT
CRH Medical Corporation (TSX: CRH)(OTCQX: CRMMF) ("CRH"
, a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, today announced that its common shares have been approved for listing on the NYSE MKT, LLC (the "NYSE MKT" subject to continued satisfaction of listing requirements. CRH anticipates its common shares will begin trading on the NYSE MKT under the ticker "CRHM" on September 3, 2015. The Company's common stock will be dual listed and will continue to trade on the TSX under its existing symbol "CRH."
CRH.TO: 4.20 (-0.13)
CRH Medical Corporation Announces Anesthesia Services Transaction
Marketwired - Tue Aug 18, 3:24PM CDT
CRH Medical Corporation (TSX: CRH)(OTCQX: CRMMF) ("CRH" or the "Company" , a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, today announced the completion of a strategic transaction whereby CRH has acquired the GI anesthesia business of Associates of Digestive Health, LLC ("ADH" . ADH is a growing gastroenterology practice located in Cape Coral, Florida that performs approximately 10,000 endoscopic procedures annually and is expected to generate annual revenues for CRH of approximately US$3,000,000. The transaction consideration was funded using cash on hand.
CRH.TO: 4.20 (-0.13)
CRH Medical Corporation Announces Filing for a US Listing
PR Newswire - Mon Aug 17, 7:00AM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF) ("CRH" , a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, has filed a Registration Statement on Form 40-F (the "Registration Statement" with the United States Securities and Exchange Commission. CRH also announced that it has submitted an original listing application to list its common shares for trading on the NYSE MKT, LLC. The Registration Statement has not yet become effective.
CRH.TO: 4.20 (-0.13)
CRH Medical Announces Second Quarter 2015 Results
Marketwired - Thu Jul 30, 7:31AM CDT
CRH Medical Corporation (TSX: CRH)(OTCQX: CRMMF) ("CRH" or the "Company" , a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, today announced its unaudited interim financial results for the quarter ended June 30, 2015. All financial results are expressed in U.S. dollars.
CRH.TO: 4.20 (-0.13)
CRH Medical Announces Date for Second Quarter 2015 Results and Conference Call
Marketwired - Tue Jul 28, 12:33PM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, today announced that it plans to release its financial results for the second quarter ended June 30, 2015, at 8:30 am ET on Thursday, July 30, 2015.
CRH.TO: 4.20 (-0.13)
CRH Medical Joins Preventing Colorectal Cancer Membership
PRWeb - Thu Jul 23, 2:06AM CDT
Not-for-profit advocacy organization Preventing Colorectal Cancer (PCC) is pleased to welcome CRH Medical to its membership. Founded in 2008, PCC's mission is to educate the public and key stakeholders about the opportunities to reduce the incidence of colorectal cancer through regular screening and care options for patients and clinicians.
CRH Medical Announces Voting Results of Shareholders Meeting
CNW Group - Thu Apr 30, 6:49PM CDT
CRH Medical Corporation (the "Company" (TSX: CRH) (OTCQX: CRMMF), announces the following voting results for the Company's 2015 Annual Meeting of Shareholders (the "Meeting" . At the Meeting the nominees listed in the Company's management proxy circular were re-elected as directors, and KPMG LLP was appointed as auditor of the Company for the coming year.
CRH.TO: 4.20 (-0.13)
CRH Medical Announces First Quarter 2015 Results
CNW Group - Wed Apr 29, 7:30AM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF) ("CRH" or the "Company" , a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, today announced its unaudited interim financial results for the quarter ended March 31, 2015. All financial results are expressed in U.S. dollars.
CRH.TO: 4.20 (-0.13)
CRH Medical Announces Date for First Quarter 2015 Results and Conference Call
CNW Group - Fri Apr 24, 10:48AM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company that provides physicians with innovative products for the treatment of gastrointestinal diseases, today announced that it plans to release its financial results for the first quarter ended March 31, 2015, at 8:30 am ET on Wednesday, April 29, 2015.
CRH.TO: 4.20 (-0.13)
Knight Therapeutics' Secured Lending Strategy Validated by CRH Medical Corporation
Marketwired - Wed Mar 25, 5:04PM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company" , a leading Canadian specialty pharmaceutical company, announced today that it successfully helped finance CRH Medical Corporation's (TSX: CRH) (OTCQX: CRMMF) ("CRH" U.S. expansion as best evidenced by CRH's recent equity offering: CRH raised $27.37 million of equity at $3.40 per share, more than triple the share price from when Knight extended the secured loan less than four months ago, in the public markets and is using such proceeds to retire USD$7.9 million of its secured debt to Knight. CRH is a North American medical company focused on providing physicians with innovative products and services for the treatment of gastrointestinal diseases.
CRH.TO: 4.20 (-0.13), GUD.TO: 8.61 (-0.09)
CRH Medical Closes Bought Deal Financing for Gross Proceeds of C$27,370,000
CNW Group - Wed Mar 25, 8:17AM CDT
CRH Medical Corporation (TSX: CRH) ("CRH" or the "Company" is pleased to announce that it has closed its previously announced bought deal equity offering (the "Offering" of 7,000,000 common shares (the "Common Shares" of the Company at a price of C$3.40 per Common Share (the "Offering Price" . The Underwriters (as defined below) were granted an over-allotment option to purchase an additional 1,050,000 Common Shares at the Offering Price, which was exercised in full, for aggregate gross proceeds of C$27,370,000 before deducting applicable commissions and expenses.
CRH.TO: 4.20 (-0.13)
Leading 100 Global Most Profitable Medical Devices/Technology/Supplies Companies 2015
M2 - Tue Mar 24, 7:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/q765nw/global_most) has announced the addition of the "Global Most Profitable Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 Most Profitable medical devices/technology/supplies companies globally and covers various aspects of these 100 companies including news, financial/non-financial information and stock market analysis. The medical device industry thrives on the innovations generated by its large base of privately held start-ups and small companies with less than 50 employees. Eighty-five percent of new medical product introductions come from these businesses, according to the Medical Device Manufacturers Association (MDMA), yet profitability seldom occurs until after a company's first $100-150 million in revenues. After passing this size, many companies struggle to attain and maintain profitable growth due to product and operational complexities as well as regulatory, legal, and financial risks. Product innovation is seen as the lifeblood of a medical device company by executives, investors, and the marketplace. Medical device companies have the opportunity to grow and thrive with shifting worldwide demographics. However, to do so, innovation must focus on how to ensure not only breakthrough products, but sound business processes that can reliable generate profit. Report Highlights: - Global Most Profitable 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Most Profitable medical devices/technology/supplies companies with foreign companies - International presence of Global Most Profitable medical devices/technology/supplies companies - Key R&D activities by Global Most Profitable medical devices/technology/supplies companies Companies Mentioned (Partial List) - Agappe Diagnostics Limited (India) - Atcor Medical Holdings Ltd (Australia) - Cellavision AB (Sweden) - CRH Medical Corp. (Canada) - Fielmann AG (Germany) - Innovative Instrument Pvt Ltd (India) - IRadimed Corp (United States) - IVF Hartmann Holding AG (Switzerland) - Kinship Technologies Private Limited (India) - Medical International Technology Inc (United States) - Oculus Innovative Sciences, Inc. (United States) - Poly Medicure Ltd. (India) - Pulsion Medical Systems Aktiengesellschaft (Germany) - Sekonix Co Ltd (South Korea) - Siemens Hearing Instrument Pvt Ltd (India) - Stericat Gut Strings Private Limited (India) - Teleflex Medical Private Ltd (India) - UMS United Medical Systems International AG (Germany) - Viveve Medical Inc (United States) For more information visit http://www.researchandmarkets.com/research/q7...lobal_most
IRMD: 19.14 (+0.32), MDSY: 1.60 (+0.20), OCLS: 0.99 (+0.01)
OTC Markets Group Congratulates CRH Medical on NYSE MKT Listing
PR Newswire - Thu Sep 03, 12:54PM CDT
OTC Markets Group Inc. (OTCQX: OTCM) is pleased to congratulate CRH Medical Corp., a provider of innovative products and services for the treatment of gastrointestinal diseases, on its NYSE MKT listing. CRH Medical previously traded on the OTCQX® Best Market operated by OTC Markets Group.
CRH Medical Corporation To Commence Trading on the NYSE MKT Under the Symbol "CRHM"
Marketwired - Tue Sep 01, 7:31AM CDT
CRH Medical Corporation (TSX: CRH)(OTCQX: CRMMF) ("CRH"
, a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, today announced that its common shares have been approved for listing on the NYSE MKT, LLC (the "NYSE MKT" subject to continued satisfaction of listing requirements. CRH anticipates its common shares will begin trading on the NYSE MKT under the ticker "CRHM" on September 3, 2015. The Company's common stock will be dual listed and will continue to trade on the TSX under its existing symbol "CRH." CRH.TO: 4.20 (-0.13)
CRH Medical Corporation Announces Anesthesia Services Transaction
Marketwired - Tue Aug 18, 3:24PM CDT
CRH Medical Corporation (TSX: CRH)(OTCQX: CRMMF) ("CRH" or the "Company"
, a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, today announced the completion of a strategic transaction whereby CRH has acquired the GI anesthesia business of Associates of Digestive Health, LLC ("ADH" . ADH is a growing gastroenterology practice located in Cape Coral, Florida that performs approximately 10,000 endoscopic procedures annually and is expected to generate annual revenues for CRH of approximately US$3,000,000. The transaction consideration was funded using cash on hand. CRH.TO: 4.20 (-0.13)
CRH Medical Corporation Announces Filing for a US Listing
PR Newswire - Mon Aug 17, 7:00AM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF) ("CRH"
, a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, has filed a Registration Statement on Form 40-F (the "Registration Statement" with the United States Securities and Exchange Commission. CRH also announced that it has submitted an original listing application to list its common shares for trading on the NYSE MKT, LLC. The Registration Statement has not yet become effective. CRH.TO: 4.20 (-0.13)
CRH Medical Announces Second Quarter 2015 Results
Marketwired - Thu Jul 30, 7:31AM CDT
CRH Medical Corporation (TSX: CRH)(OTCQX: CRMMF) ("CRH" or the "Company"
, a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, today announced its unaudited interim financial results for the quarter ended June 30, 2015. All financial results are expressed in U.S. dollars. CRH.TO: 4.20 (-0.13)
CRH Medical Announces Date for Second Quarter 2015 Results and Conference Call
Marketwired - Tue Jul 28, 12:33PM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, today announced that it plans to release its financial results for the second quarter ended June 30, 2015, at 8:30 am ET on Thursday, July 30, 2015.
CRH.TO: 4.20 (-0.13)
CRH Medical Joins Preventing Colorectal Cancer Membership
PRWeb - Thu Jul 23, 2:06AM CDT
Not-for-profit advocacy organization Preventing Colorectal Cancer (PCC) is pleased to welcome CRH Medical to its membership. Founded in 2008, PCC's mission is to educate the public and key stakeholders about the opportunities to reduce the incidence of colorectal cancer through regular screening and care options for patients and clinicians.
CRH Medical Announces Voting Results of Shareholders Meeting
CNW Group - Thu Apr 30, 6:49PM CDT
CRH Medical Corporation (the "Company"
(TSX: CRH) (OTCQX: CRMMF), announces the following voting results for the Company's 2015 Annual Meeting of Shareholders (the "Meeting" . At the Meeting the nominees listed in the Company's management proxy circular were re-elected as directors, and KPMG LLP was appointed as auditor of the Company for the coming year. CRH.TO: 4.20 (-0.13)
CRH Medical Announces First Quarter 2015 Results
CNW Group - Wed Apr 29, 7:30AM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF) ("CRH" or the "Company"
, a North American medical company that provides physicians with innovative products and services for the treatment of gastrointestinal diseases, today announced its unaudited interim financial results for the quarter ended March 31, 2015. All financial results are expressed in U.S. dollars. CRH.TO: 4.20 (-0.13)
CRH Medical Announces Date for First Quarter 2015 Results and Conference Call
CNW Group - Fri Apr 24, 10:48AM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company that provides physicians with innovative products for the treatment of gastrointestinal diseases, today announced that it plans to release its financial results for the first quarter ended March 31, 2015, at 8:30 am ET on Wednesday, April 29, 2015.
CRH.TO: 4.20 (-0.13)
Knight Therapeutics' Secured Lending Strategy Validated by CRH Medical Corporation
Marketwired - Wed Mar 25, 5:04PM CDT
Knight Therapeutics Inc. (TSX: GUD) ("Knight" or the "Company"
, a leading Canadian specialty pharmaceutical company, announced today that it successfully helped finance CRH Medical Corporation's (TSX: CRH) (OTCQX: CRMMF) ("CRH" U.S. expansion as best evidenced by CRH's recent equity offering: CRH raised $27.37 million of equity at $3.40 per share, more than triple the share price from when Knight extended the secured loan less than four months ago, in the public markets and is using such proceeds to retire USD$7.9 million of its secured debt to Knight. CRH is a North American medical company focused on providing physicians with innovative products and services for the treatment of gastrointestinal diseases. CRH.TO: 4.20 (-0.13), GUD.TO: 8.61 (-0.09)
CRH Medical Closes Bought Deal Financing for Gross Proceeds of C$27,370,000
CNW Group - Wed Mar 25, 8:17AM CDT
CRH Medical Corporation (TSX: CRH) ("CRH" or the "Company"
is pleased to announce that it has closed its previously announced bought deal equity offering (the "Offering" of 7,000,000 common shares (the "Common Shares" of the Company at a price of C$3.40 per Common Share (the "Offering Price" . The Underwriters (as defined below) were granted an over-allotment option to purchase an additional 1,050,000 Common Shares at the Offering Price, which was exercised in full, for aggregate gross proceeds of C$27,370,000 before deducting applicable commissions and expenses. CRH.TO: 4.20 (-0.13)
Leading 100 Global Most Profitable Medical Devices/Technology/Supplies Companies 2015
M2 - Tue Mar 24, 7:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/q765nw/global_most) has announced the addition of the "Global Most Profitable Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. This newly launched report identifies 100 Most Profitable medical devices/technology/supplies companies globally and covers various aspects of these 100 companies including news, financial/non-financial information and stock market analysis. The medical device industry thrives on the innovations generated by its large base of privately held start-ups and small companies with less than 50 employees. Eighty-five percent of new medical product introductions come from these businesses, according to the Medical Device Manufacturers Association (MDMA), yet profitability seldom occurs until after a company's first $100-150 million in revenues. After passing this size, many companies struggle to attain and maintain profitable growth due to product and operational complexities as well as regulatory, legal, and financial risks. Product innovation is seen as the lifeblood of a medical device company by executives, investors, and the marketplace. Medical device companies have the opportunity to grow and thrive with shifting worldwide demographics. However, to do so, innovation must focus on how to ensure not only breakthrough products, but sound business processes that can reliable generate profit. Report Highlights: - Global Most Profitable 100 medical devices/technology/supplies companies - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances of Global Most Profitable medical devices/technology/supplies companies with foreign companies - International presence of Global Most Profitable medical devices/technology/supplies companies - Key R&D activities by Global Most Profitable medical devices/technology/supplies companies Companies Mentioned (Partial List) - Agappe Diagnostics Limited (India) - Atcor Medical Holdings Ltd (Australia) - Cellavision AB (Sweden) - CRH Medical Corp. (Canada) - Fielmann AG (Germany) - Innovative Instrument Pvt Ltd (India) - IRadimed Corp (United States) - IVF Hartmann Holding AG (Switzerland) - Kinship Technologies Private Limited (India) - Medical International Technology Inc (United States) - Oculus Innovative Sciences, Inc. (United States) - Poly Medicure Ltd. (India) - Pulsion Medical Systems Aktiengesellschaft (Germany) - Sekonix Co Ltd (South Korea) - Siemens Hearing Instrument Pvt Ltd (India) - Stericat Gut Strings Private Limited (India) - Teleflex Medical Private Ltd (India) - UMS United Medical Systems International AG (Germany) - Viveve Medical Inc (United States) For more information visit http://www.researchandmarkets.com/research/q7...lobal_most
IRMD: 19.14 (+0.32), MDSY: 1.60 (+0.20), OCLS: 0.99 (+0.01)
(0)
(0)